IMMX logo

Immix Biopharma, Inc.

IMMX
Healthcare|Biotechnology|US
$8.06
+0.86 (+11.94%)
DCF Value
$2.66
Tangible Book / Share
$3.59
Cash / Share
$3.64
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Sep 29, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (1)

Dec 2026
Est. completion
P1P2Light Chain (AL) Amyloidosis
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis
NCT06097832n=45

Recent Press Releases

Immix Biopharma's NXC-201 NEXICART-2 Interim Clinical Trial Results Selected for Oral Presentation at ASH 2026
Nov 4, 2026 · GlobeNewsWire
Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference
Oct 5, 2026 · GlobeNewsWire
Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock
Sep 30, 2026 · GlobeNewsWire
Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock
Sep 29, 2026 · GlobeNewsWire
Immix Biopharma Announces 89% Complete Response Rate at Interim Update Across All NEXICART-2 Patients, with MRD-Negativity Indicating Potential to Reach up to 98% Complete Response Rate, Supporting Potential Best-in-Class Therapy for Relapsed/Refractory AL Amyloidosis
Sep 29, 2026 · GlobeNewsWire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc. - IMMX
Aug 13, 2026 · PRNewsWire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc. - IMMX
Aug 11, 2026 · GlobeNewsWire

SEC Filings (55)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 27, 2026SC 13GPassive 5%+ stakeDocumentIndex
Sep 30, 20268-KMaterial eventDocumentIndex
Sep 29, 2026FWPDocumentIndex
Sep 29, 2026424B5Offering prospectusDocumentIndex
Sep 29, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 7, 202610-QQuarterly reportDocumentIndex
Jul 20, 20268-KMaterial eventDocumentIndex
Jun 5, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 29, 20268-KMaterial eventDocumentIndex
May 21, 20268-KMaterial eventDocumentIndex
May 21, 2026424B5Offering prospectusDocumentIndex
May 21, 2026FWPDocumentIndex
May 21, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
May 4, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 6, 2026ARSAnnual report to holdersDocumentIndex
Apr 6, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 6, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 30, 20268-KMaterial eventDocumentIndex
Mar 27, 202610-K/AAnnual reportDocumentIndex
Mar 25, 2026S-8Employee stock planDocumentIndex
Mar 25, 20268-KMaterial eventDocumentIndex
Mar 25, 2026424B5Offering prospectusDocumentIndex
Mar 25, 202610-KAnnual reportDocumentIndex
Mar 20, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 22, 2026EFFECTDocumentIndex
Jan 9, 2026S-3Shelf registrationDocumentIndex
Dec 8, 20258-KMaterial eventDocumentIndex
Dec 8, 2025424B5Offering prospectusDocumentIndex
Dec 8, 20258-KMaterial eventDocumentIndex
Dec 8, 2025FWPDocumentIndex
Dec 1, 2025EFFECTDocumentIndex
Nov 26, 20258-KMaterial eventDocumentIndex
Nov 7, 202510-QQuarterly reportDocumentIndex
Oct 6, 2025S-3Shelf registrationDocumentIndex